Therapeutics for inflammation, metabolic dysfunction and lysosomal function
Location: United States, California, South San Francisco
Total raised: $200M
Investors 2
| Date | Name | Website |
| 17.05.2025 | ARCH Ventu... | archventur... |
| 23.01.2025 | Eight Road... | eightroads... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.01.2025 | - | $200M | - |
Mentions in press and media 3
| Date | Title | Description |
| 08.01.2025 | Tenvie Therapeutics Raises $200M in Funding | Tenvie Therapeutics, a San Francisco, CA-based biotechnology company committed to engineering small molecules for the treatment of neurological diseases, raised $200M in funding. The round was led by ARCH Venture Partners, F-Prime Capital, ... |
| 08.01.2025 | Tenvie Therapeutics Launches with $200M Funding | SOUTH SAN FRANCISCO, CA, Tenvie Therapeutics launched with $200 million in funding led by ARCH Venture Partners, F-Prime Capital, Mubadala Capital. >> Click here for more funding data on Tenvie Therapeutics >> To export Tenvie ... |
| - | Tenvie Therapeutics | “Homepage - tenvie” |